Jim Simons Guardant Health, Inc. Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Guardant Health, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 438,400 shares of GH stock, worth $16.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

438,400

Holding current value

$16.1 Million

% of portfolio

0.02%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$22.3 - $36.29 $9.78 Million - $15.9 Million	438,400 New	438,400 $10.1 Million
Q1 2023 May 12, 2023	BUY	$22.92 - $33.76 $4.89 Million - $7.2 Million	213,400 New	213,400 $5 Million
Q2 2021 Aug 13, 2021	SELL	$109.77 - $165.68 $9.6 Million - $14.5 Million	-87,500 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$127.04 - $179.1 $5.34 Million - $7.52 Million	-42,000 Reduced 32.43%	87,500 $13.4 Million
Q4 2020 Feb 10, 2021	BUY	$99.96 - $135.93 $12.9 Million - $17.6 Million	129,500 New	129,500 $16.7 Million
Q3 2020 Nov 13, 2020	SELL	$80.32 - $111.8 $10.3 Million - $14.3 Million	-128,300 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$60.49 - $97.5 $7.76 Million - $12.5 Million	128,300 New	128,300 $10.4 Million
Q4 2019 Feb 13, 2020	SELL	$59.49 - $82.78 $19.1 Million - $26.5 Million	-320,600 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$62.59 - $110.3 $20.1 Million - $35.4 Million	320,600 New	320,600 $20.5 Million

Others Institutions Holding GH

# of Institutions

323

Shares Held

127M

Call Options Held

844K

Put Options Held

2.38M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.75B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account